June 10, 2021
UCLA scientists have recently published a study using a mouse research model, which found that a class of drugs commonly prescribed to treat depression (MAOIs) could also activate the immune system to shrink various types of tumors. The senior author of this study is microbiology immunology and molecular genetics associate professor, Lili Yang. Read more about this research in this UCLA Newsroom article.